Imagion Biosystems Statistics
Total Valuation
IBXXF has a market cap or net worth of 1.67 million. The enterprise value is 1.78 million.
| Market Cap | 1.67M |
| Enterprise Value | 1.78M |
Important Dates
The next estimated earnings date is Friday, May 30, 2025.
| Earnings Date | May 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +47.45% |
| Shares Change (QoQ) | +75.55% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 153.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.01 |
| PB Ratio | -1.18 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.39 |
| EV / Sales | 1.05 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.55
| Current Ratio | 0.55 |
| Quick Ratio | 0.53 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.65 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -12.64% |
| Return on Invested Capital (ROIC) | -33.20% |
| Return on Capital Employed (ROCE) | 32.75% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.72 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.09% in the last 52 weeks. The beta is 1.80, so IBXXF's price volatility has been higher than the market average.
| Beta (5Y) | 1.80 |
| 52-Week Price Change | -96.09% |
| 50-Day Moving Average | 0.77 |
| 200-Day Moving Average | 2.08 |
| Relative Strength Index (RSI) | 44.23 |
| Average Volume (20 Days) | 7,696 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IBXXF had revenue of 1.65 million and -1.28 million in losses. Loss per share was -0.03.
| Revenue | 1.65M |
| Gross Profit | 1.40M |
| Operating Income | -462,634 |
| Pretax Income | -1.28M |
| Net Income | -1.28M |
| EBITDA | -433,248 |
| EBIT | -462,634 |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 1.65 million in cash and 1.76 million in debt, giving a net cash position of -109,403.
| Cash & Cash Equivalents | 1.65M |
| Total Debt | 1.76M |
| Net Cash | -109,403 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -1.41M |
| Book Value Per Share | -0.01 |
| Working Capital | -1.42M |
Cash Flow
| Operating Cash Flow | -786,318 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 84.95%, with operating and profit margins of -28.05% and -77.56%.
| Gross Margin | 84.95% |
| Operating Margin | -28.05% |
| Pretax Margin | -77.56% |
| Profit Margin | -77.56% |
| EBITDA Margin | -26.27% |
| EBIT Margin | -28.05% |
| FCF Margin | n/a |
Dividends & Yields
IBXXF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -47.45% |
| Shareholder Yield | -47.45% |
| Earnings Yield | -76.56% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on November 16, 2023. It was a reverse split with a ratio of 0.025.
| Last Split Date | Nov 16, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.025 |
Scores
IBXXF has an Altman Z-Score of -34.04. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -34.04 |
| Piotroski F-Score | n/a |